netFormulary Birmingham, Sandwell, Solihull and environs APC Formulary NHS
Maintained by Midlands and Lancashire Commissioning Support Unit  
 Search
 Formulary Chapter 5: Infections - Full Section
Notes:
Broad-spectrum antibiotics SHOULD NOT be used outside of the Primary Care Antimicrobial Guidelines, unless recommended by a specialist, in line with antimicrobial stewardship.
Please be aware that all GREEN drugs are only green if used in line with antimicrobial guidelines. 
 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
05.01 Antibacterial drugs (0,0)
Table 1. Summary of antibacterial therapy (0,0)
Table 2. Summary of antibacterial prophylaxis (0,0)
05.01.01 Penicillins (0,0)
05.01.01.01 Benzylpenicillin and phenoxymethylpenicillin (4,0)
05.01.01.02 Penicillinase-resistant penicillins (3,0)
05.01.01.03 Broad-spectrum penicillins (4,4)
05.01.01.04 Antipseudomonal penicillins (2,0)
05.01.01.05 Mecillinams (1,0)
05.01.02 Cephalosporins, carbapenems and other beta-lactums (0,0)
Cephalosporins (0,0)
Other beta-lactam antibiotics (0,0)
05.01.02.01 Cephalosporins (5,6)
05.01.02.02 Carbapenems (3,0)
05.01.02.03 Other beta-lactums antibiotics (1,1)
05.01.03 Tetracyclines (7,1)
Tigecycline (1,0)
05.01.04 Aminoglycosides (5,3)
05.01.05 Macrolides (7,1)
05.01.06 Clindamycin (2,0)
05.01.07 Some other antibacterials (0,1)
Chloramphenicol (1,0)
Fosfomycin (0,0)
Fusidic acid (0,2)
Vancomycin and teicoplanin (3,0)
Daptomycin (1,0)
Linezolid (2,0)
Quinupristin and dalfopristin (0,1)
Polymyxins (3,0)
Rifaximin (1,0)
Fidaxomicin (1,0)
05.01.08 Sulphonamides and trimethoprim (4,0)
05.01.09 Antituberculosis drugs (10,4)
05.01.10 Antileprotic drugs (1,2)
05.01.11 Metronidazole and tinidazole (4,0)
05.01.12 Quinolones (7,1)
05.01.13 Urinary-tract infections (3,0)
05.02 Antifungal drugs (10,2)
Treatment of fungal infections (0,0)
Drugs used in fungal infections (0,1)
05.02.01 Triazole antifungals (0,0)
05.02.02 Imidazole antifungals (0,0)
05.02.03 Polyene antifungals (0,0)
05.02.04 Echinocandin antifungals (3,0)
05.02.05 Other antifungals (0,1)
05.03 Antiviral drugs (0,0)
05.03.01 HIV infection (0,1)
Nucleoside reverse transcriptase inhibitors (13,3)
Protease inhibitors (6,3)
Non-nucleoside reverse transcriptase inhibitors (3,0)
Other antiretrovirals (2,1)
Pharmacokinetic enhancers of antiretrovirals (0,0)
05.03.02 Herpesvirus infections (0,1)
05.03.02.01 Herpes simplex and varicella-zoster infection (4,1)
05.03.02.02 Cytomegalovirus infection (3,1)
05.03.03 Viral hepatitis (4,0)
05.03.03.01 Chronic hepatitis B (1,0)
05.03.03.02 Chronic hepatitis C (5,1)
05.03.04 Influenza (2,3)
05.03.05 Respiratory syncytial virus (2,0)
05.04 Antiprotozoal drugs (0,0)
05.04.01 Antimalarials (0,0)
Treatment of malaria (0,0)
Falciparum malaria (treatment) (0,0)
Benign malarias (treatment) (0,0)
Prophylaxis against malaria (0,0)
Specific recommendations (0,0)
Artemether with lumefabtrine (1,0)
Chloroquine (1,4)
Mefloquine (1,0)
Primaquine (1,0)
Proguanil (2,2)
Pyrimethamine (1,2)
Quinine (2,1)
Tetracyclines (0,1)
05.04.02 Amoebicides (1,2)
05.04.03 Trichomonacides (0,1)
05.04.04 Antigiardial drugs (1,1)
05.04.05 Leishmaniacides (1,1)
05.04.06 Trypanocides (0,0)
05.04.07 Drugs for toxoplasmosis (1,1)
05.04.08 Drugs for pneumocystis pneumonia (2,1)
Treatment (0,0)
Prophylaxis (0,0)
05.05 Anthelmintics (0,0)
05.05.01 Drugs for threadworms (1,2)
05.05.02 Ascaricides (1,0)
05.05.03 Drugs for tapeworm infections (0,1)
Taenicides (0,0)
Hydatid disease (0,0)
05.05.04 Drugs for hookworms (0,0)
05.05.05 Schistosomicides (1,0)
05.05.06 Filaricides (1,0)
05.05.07 Drugs for cutaneous larva migrans (0,1)
05.05.08 Drugs for strongyloidiasis (1,0)
netFormulary